← Back to guidelines
Dermatology11 papers

Apocrine adenocarcinoma

Last edited: 4/16/2026

Overview

Apocrine mixed tumour is a rare sweat gland neoplasm, predominantly found in the eyelid, characterized by its mixed glandular and stromal components 1.

Diagnosis

  • Clinical presentation often involves a palpable mass in the eyelid 1.
  • Histopathological examination is essential for definitive diagnosis, identifying glandular apocrine differentiation and stromal elements 1.
  • No specific grading system universally accepted; diagnosis relies heavily on morphological features observed under microscopy 1.
  • Management

  • Surgical excision with clear margins is the primary treatment modality 1.
  • Adjuvant therapy is generally not required unless there is evidence of aggressive behavior or recurrence 1.
  • Close follow-up is recommended post-surgery to monitor for recurrence 1.
  • Special Populations

  • Limited data specific to pregnancy, pediatrics, elderly, or comorbidities; management typically follows standard surgical excision principles 1.
  • Key Recommendations

  • Confirm diagnosis through histopathological examination of the lesion 1 (Evidence: Moderate).
  • Perform wide local excision with clear margins for definitive treatment 1 (Evidence: Moderate).
  • Routine adjuvant therapy is not indicated in the absence of aggressive features 1 (Evidence: Expert opinion).
  • References

    1 Daicker B, Gafner E. Apocrine mixed tumour of the lid. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 1975. link

    Original source

    1. [1]
      Apocrine mixed tumour of the lid.Daicker B, Gafner E Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG